Among the many things columnist Candace Semien had to learn while living with lupus were the types and function of various ...

TFAM is a protein critical for maintaining the integrity of mitochondrial DNA, and is among the molecules mitochondria release as a stress signal. But the potential role of TFAM in driving SLE-related ...

If my body contributed to the Job of Living, it was limited to completing and surviving the day’s tasks and soaking in only essential oils and hot water. While I strategically planned to execute the ...

Fast track status is given to therapies that have the potential to improve care for serious diseases, with the goal of speeding the review and development of possibly important new treatments. The FDA ...

If I met someone special, how and when should I tell them about my diagnosis? How would I handle their reaction, especially if it wasn’t positive? First, let me share my thoughts about approach and ...

The trial, called Ntrust-1, is a multicenter and open-label study to assess the safety, efficacy, and clinical activity of NKX019 in up to 12 patients with refractory lupus nephritis. Study results ...

His soulful, smooth voice continues: “Yeah, let yourself go, follow that feeling/ Maybe something new is what you’re needing/ Like a real night, let your hair down, feel alive.” Doing something for ...

The machine learning model was tested on 983 patients, who were not part of the initial datasets, to demonstrate that they could be classified into one of the eight endotypes. Each patient is given a ...

For me, spring and summer are my two most dreaded seasons. Like clockwork each year, the combination of the blazing sun and the stifling heat cause a flare-up that lasts three to four months. Add in ...

The isolated T-cells are sent to a lab, where they are genetically engineered to be equipped with a chimeric antigen receptor (CAR) that recognizes a specific target of interest. In the case of CAR ...

The Phase 1 study will enroll people with moderate to severe SLE who’ve failed to respond to at least two standard immunosuppressive medications. Century expects the trial will start in the first half ...

The number of lupus nephritis flares, or periods of sudden worsening, also dropped by more than half in patients given Gazyva as an add-on treatment relative to those given a placebo. That’s according ...